NCT04829591Completed
A Multicenter Registry to Study the Characteristics and Outcomes of Jordanian Heart Failure Patients.
The Jordanian Heart Failure Registry (JoHFR)
Source: ClinicalTrials.gov · Last updated 19 Jul 2024
Brief summary (registry, in English)
Heart Failure research registry is a collection of computerized information about individuals with heart failure. The database in this registry is obtained from several Jordanian medical centers which will represent an extremely valuable resource for epidemiological research on heart failure patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 2219 (actual)
- First submitted
- 31 Mar 2021
- Start date
- 1 Jul 2021
- Primary completion date
- 30 Dec 2023
- Lead sponsor
- Jordan Cardio Vascular Research Group
- Diseases
- Heart failure
- NCT number
- NCT04829591
What you commit to
- Study type: Observational
- Participants enrolled: 2219
- From 1 Jul 2021 to the primary completion date, 30 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients who refuse or unable to sign a consent form.
- Patient inability to follow up with provider
Who the study is looking for
- Patients who are 18 years or older with Heart Failure diagnosis as defined by internationally recognized guidelines.
- Current residents of the Hashemite Kingdom of Jordan
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Farah Medical Campus Coordinator of this site? Confirm its status | Amman | Jordan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.